The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy.

PubWeight™: 1.50‹?› | Rank: Top 4%

🔗 View Article (PMC 1235088)

Published in Ann Surg on February 01, 1996

Authors

K C Conlon1, E Dougherty, D S Klimstra, D G Coit, A D Turnbull, M F Brennan

Author Affiliations

1: Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Articles citing this

Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg (2005) 2.18

Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol (2011) 1.65

An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models. J Am Coll Surg (2012) 1.46

Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection? Ann Surg (1996) 1.36

Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer. Hepatogastroenterology (2012) 1.31

Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg (2002) 1.22

Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg (2003) 1.20

Fluorescence laparoscopy imaging of pancreatic tumor progression in an orthotopic mouse model. Surg Endosc (2010) 1.20

Laparoscopic ultrasound enhances standard laparoscopy in the staging of pancreatic cancer. Ann Surg (1998) 1.12

Surgery for periampullary and pancreatic carcinoma: a Liverpool experience. Ann R Coll Surg Engl (1997) 1.12

Diagnostic laparoscopy improves staging of pancreatic cancer deemed locally unresectable by computed tomography. Surg Endosc (2005) 1.10

Fluorescence-guided surgery and fluorescence laparoscopy for gastrointestinal cancers in clinically-relevant mouse models. Gastroenterol Res Pract (2013) 1.04

Recent advances in the surgical treatment of pancreatic cancer. World J Gastroenterol (2001) 1.03

Assessment of pancreatic malignancy with laparoscopy and intraoperative ultrasound. Surg Endosc (2006) 1.02

Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management. World J Gastroenterol (2010) 0.96

Controversies in the management of borderline resectable proximal pancreatic adenocarcinoma with vascular involvement. HPB Surg (2009) 0.90

Ultrafast magnetic resonance imaging improves the staging of pancreatic tumors. Ann Surg (1997) 0.90

The role of staging laparoscopy for intraabdominal cancers: an evidence-based review. Surg Endosc (2008) 0.88

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer. World J Surg Oncol (2012) 0.87

Laparoscopic staging and surgical treatment of pancreatic cancer. N Am J Med Sci (2013) 0.87

Role of staging laparoscopy in peri-pancreatic and hepatobiliary malignancy. World J Gastrointest Surg (2010) 0.86

Usefulness of follow-up after pancreatoduodenectomy for carcinoma of the ampulla of Vater. HPB (Oxford) (2007) 0.83

The effects of staging laparoscopy on trocar site and peritoneal recurrence of pancreatic cancer. Surg Endosc (2003) 0.81

Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. HPB (Oxford) (2014) 0.79

KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression. World J Gastroenterol (2005) 0.79

Neoadjuvant strategies for pancreatic cancer. World J Gastroenterol (2014) 0.79

Our local experience with the surgical treatment of ampullary cancer. Int Semin Surg Oncol (2005) 0.77

Imaging for the diagnosis and staging of periampullary carcinomas. Surg Endosc (2003) 0.77

Laparoscopic liver resections. J Minim Access Surg (2005) 0.75

The impact of laparoscopy on cancer management. Surg Endosc (2000) 0.75

Articles cited by this

Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet (1987) 3.84

Cancer statistics, 1992. CA Cancer J Clin (1992) 2.99

Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg (1988) 2.74

Endoscopic ultrasonography in the diagnosis and staging of pancreatic adenocarcinoma. Results of a prospective study with comparison to ultrasonography and CT scan. Endoscopy (1993) 2.31

Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg (1992) 1.91

Preoperative staging and assessment of resectability of pancreatic cancer. Arch Surg (1990) 1.84

Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg (1991) 1.79

Laparoscopy in the staging and planning of therapy for pancreatic cancer. Am J Surg (1986) 1.47

Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms. Am J Surg (1994) 1.25

Is preoperative angiography useful in patients with periampullary tumors? Ann Surg (1990) 1.24

The diagnosis of pancreatic cancer by endoscopic ultrasonography. Gastrointest Endosc (1988) 1.21

Diagnosis and staging of pancreatic adenocarcinoma with dynamic computed tomography. Am J Surg (1993) 1.17

Laparoscopy for pancreatic cancer: does it benefit the patient? Eur J Surg Oncol (1988) 1.03

Cancer of the pancreas. Gut (1990) 0.99

Malignant biliary obstruction: efficacy of thin-section dynamic CT in determining resectability. AJR Am J Roentgenol (1992) 0.97

The use of operative sonography in carcinoma of the pancreas. World J Surg (1987) 0.96

Peritoneoscopy and pancreas biopsy in the diagnosis of pancreatic diseases. Gastrointest Endosc (1983) 0.94

The staging of pancreatic adenocarcinoma. Clin Radiol (1993) 0.88

[Laparoscopic assessment of the operability of pancreatic cancer]. Khirurgiia (Sofiia) (1989) 0.79

Articles by these authors

Gene-expression profiles in hereditary breast cancer. N Engl J Med (2001) 29.80

Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31

Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg (2000) 13.24

Impact of hospital volume on operative mortality for major cancer surgery. JAMA (1998) 11.05

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med (1999) 7.04

Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol (2001) 6.30

Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg (1993) 6.15

Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg (1995) 5.90

Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg (1998) 5.87

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. J Clin Oncol (1996) 5.40

Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88

Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg (1996) 4.51

SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med (1998) 4.18

Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol (1996) 3.85

Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum (2004) 3.12

Preoperative biliary drainage: impact on intraoperative bile cultures and infectious morbidity and mortality after pancreaticoduodenectomy. J Gastrointest Surg (2000) 3.06

Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res (1994) 2.98

Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91

The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer (1999) 2.90

Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87

Major hepatic resection for neoplasia: personal experience in 108 patients. Ann Surg (1978) 2.80

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res (2001) 2.80

The National Cancer Data Base report on pancreatic cancer. Cancer (1995) 2.77

Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74

Gastrointestinal autonomic nerve tumors. A clinicopathological, immunohistochemical, and ultrastructural study of 12 cases. Am J Surg Pathol (1993) 2.71

Myoepithelial carcinoma of the salivary glands: a clinicopathologic study of 25 patients. Am J Surg Pathol (2000) 2.70

Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg (1999) 2.65

Soft tissue sarcomas. Curr Probl Surg (1996) 2.62

Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol (1999) 2.61

Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer (1989) 2.57

The enigma of desmoid tumors. Ann Surg (1999) 2.57

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47

Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg (1996) 2.39

Metastatic breast cancer masquerading as gastrointestinal primary. Am J Gastroenterol (1998) 2.33

Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32

Subclassification of gastrointestinal stromal tumors based on evaluation by electron microscopy and immunohistochemistry. Ultrastruct Pathol (1996) 2.31

Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol (1999) 2.30

Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol (2000) 2.22

Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19

Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17

Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. J Clin Oncol (1997) 2.10

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09

Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma. Ann Surg (1993) 2.07

Factors predictive of survival in ampullary carcinoma. Ann Surg (1998) 2.06

Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol (2001) 2.06

Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients. Ann Surg (2000) 2.05

Drainage is unnecessary after elective liver resection. Am J Surg (1996) 2.03

Extremity and trunk desmoid tumors: a multifactorial analysis of outcome. Cancer (1999) 2.03

Surgical management of intra-abdominal desmoid tumours. Br J Surg (2000) 2.01

Primary duodenal adenocarcinoma: a ten-year experience with 79 patients. J Am Coll Surg (1996) 1.97

The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97

Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97

The continuing challenge of retroperitoneal sarcomas. Cancer (1981) 1.95

Gallbladder cancer discovered during laparoscopic surgery. Potential for iatrogenic tumor dissemination. Arch Surg (1993) 1.94

Adult urological sarcoma. J Urol (1992) 1.94

Management of small soft-tissue sarcoma of the extremity in adults. Arch Surg (1992) 1.92

Pancreatic or liver resection for malignancy is safe and effective for the elderly. Ann Surg (1995) 1.91

Preoperative staging of gastric cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.90

Repeat resection of pulmonary metastases in patients with soft-tissue sarcoma. J Am Coll Surg (2000) 1.88

Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer (2001) 1.86

Radiation-associated sarcoma of bone and soft tissue. Arch Surg (1992) 1.84

Influence of biologic factors and anatomic site in completely resected liposarcoma. J Clin Oncol (2000) 1.83

Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol (1996) 1.82

Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol (2000) 1.81

Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol (2004) 1.80

Effect of reresection in extremity soft tissue sarcoma. Ann Surg (2000) 1.80

Uncomplicated starvation versus cancer cachexia. Cancer Res (1977) 1.79

The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases. Ann Surg (1991) 1.79

Metastatic adenocarcinoma involving a mesothelial/monocytic incidental cardiac excrescence (cardiac MICE) Am J Surg Pathol (1997) 1.79

Evaluation of palliative surgical procedures in unresectable pancreatic cancer. Br J Surg (1991) 1.79

Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer (2000) 1.78

Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol (1997) 1.77

Core needle biopsy for diagnosis of extremity soft tissue sarcoma. Ann Surg Oncol (1997) 1.75

Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer (2004) 1.75

Results of hepatic resection for sarcoma metastatic to liver. Ann Surg (2001) 1.75

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg (1996) 1.74

K-ras mutations in pancreatic ductal proliferative lesions. Am J Pathol (1994) 1.73

Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72

A prospective, randomized trial of early enteral feeding after resection of upper gastrointestinal malignancy. Ann Surg (1997) 1.69

Acrometastases. A study of twenty-nine patients with osseous involvement of the hands and feet. J Bone Joint Surg Am (1986) 1.68

Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery (1997) 1.68

Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology (1991) 1.68

The seventies evolution in liver surgery for cancer. Cancer (1981) 1.68

Arterial hemorrhage after pancreatoduodenectomy. The 'sentinel bleed'. Arch Surg (1991) 1.67

The desmoid tumor. Not a benign disease. Arch Surg (1989) 1.66